746 related articles for article (PubMed ID: 29374430)
1. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
Staszczak M
Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
Crosas B
Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
[TBL] [Abstract][Full Text] [Related]
3. 26S proteasomes become stably activated upon heat shock when ubiquitination and protein degradation increase.
Lee D; Goldberg AL
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2122482119. PubMed ID: 35704754
[TBL] [Abstract][Full Text] [Related]
4. The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.
Yerlikaya A; Kanbur E; Stanley BA; Tümer E
Anticancer Agents Med Chem; 2021; 21(1):20-32. PubMed ID: 32781973
[TBL] [Abstract][Full Text] [Related]
5. [Ubiquitin-independent protein degradation in proteasomes].
Buneeva OA; Medvedev AE
Biomed Khim; 2018 Mar; 64(2):134-148. PubMed ID: 29723144
[TBL] [Abstract][Full Text] [Related]
6. Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.
Patel K; Ahmed ZS; Huang X; Yang Q; Ekinci E; Neslund-Dudas CM; Mitra B; Elnady FA; Ahn YH; Yang H; Liu J; Dou QP
Future Med Chem; 2018 Sep; 10(17):2087-2108. PubMed ID: 30066579
[TBL] [Abstract][Full Text] [Related]
7. Targeting Deubiquitinating Enzymes and Autophagy in Cancer.
Mooneyham A; Bazzaro M
Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830
[TBL] [Abstract][Full Text] [Related]
8. Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97.
Sha Z; Goldberg AL
Curr Biol; 2014 Jul; 24(14):1573-1583. PubMed ID: 24998528
[TBL] [Abstract][Full Text] [Related]
9. Natural products inhibiting the ubiquitin-proteasome proteolytic pathway, a target for drug development.
Tsukamoto S; Yokosawa H
Curr Med Chem; 2006; 13(7):745-54. PubMed ID: 16611064
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination and deubiquitination: Implications on cancer therapy.
Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
[TBL] [Abstract][Full Text] [Related]
11. The Capture of a Disabled Proteasome Identifies Erg25 as a Substrate for Endoplasmic Reticulum Associated Degradation.
Buck TM; Zeng X; Cantrell PS; Cattley RT; Hasanbasri Z; Yates ME; Nguyen D; Yates NA; Brodsky JL
Mol Cell Proteomics; 2020 Nov; 19(11):1896-1909. PubMed ID: 32868373
[TBL] [Abstract][Full Text] [Related]
12. The 26S proteasome is a multifaceted target for anti-cancer therapies.
Grigoreva TA; Tribulovich VG; Garabadzhiu AV; Melino G; Barlev NA
Oncotarget; 2015 Sep; 6(28):24733-49. PubMed ID: 26295307
[TBL] [Abstract][Full Text] [Related]
13. Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy.
Driscoll JJ; Dechowdhury R
Target Oncol; 2010 Dec; 5(4):281-9. PubMed ID: 21125340
[TBL] [Abstract][Full Text] [Related]
14. Structure-Driven Developments of 26S Proteasome Inhibitors.
Śledź P; Baumeister W
Annu Rev Pharmacol Toxicol; 2016; 56():191-209. PubMed ID: 26738474
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinating enzymes are IN/(trinsic to proteasome function).
Guterman A; Glickman MH
Curr Protein Pept Sci; 2004 Jun; 5(3):201-11. PubMed ID: 15188770
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition promotes Parkin-Ubc13 interaction and lysine 63-linked ubiquitination.
Lim GG; Chew KC; Ng XH; Henry-Basil A; Sim RW; Tan JM; Chai C; Lim KL
PLoS One; 2013; 8(9):e73235. PubMed ID: 24023840
[TBL] [Abstract][Full Text] [Related]
17. In vitro analysis of proteasome-associated USP14 activity for substrate degradation and deubiquitylation.
Muniyappan S; Lee BH
Methods Enzymol; 2019; 619():249-268. PubMed ID: 30910023
[TBL] [Abstract][Full Text] [Related]
18. Eat or be eaten: The autophagic plight of inactive 26S proteasomes.
Marshall RS; Vierstra RD
Autophagy; 2015; 11(10):1927-8. PubMed ID: 26291247
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinating enzyme Usp14 allosterically inhibits multiple proteasomal activities and ubiquitin-independent proteolysis.
Kim HT; Goldberg AL
J Biol Chem; 2017 Jun; 292(23):9830-9839. PubMed ID: 28416611
[TBL] [Abstract][Full Text] [Related]
20. The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation.
Preston GM; Brodsky JL
Biochem J; 2017 Feb; 474(4):445-469. PubMed ID: 28159894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
